The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE150100088
Funder
Australian Research Council
Funding Amount
$700,000.00
Summary
nano infrared and sub micron Raman spectroscopy and imaging. Nano infrared and sub micron raman spectroscopy and imaging: Near-field Infrared (IR) spectroscopy and imaging systems will be coupled to near-field scanning optical microscopes to provide IR spectroscopy and molecular images at less than 20 nanometre lateral resolution. This is unprecedented resolution for infrared fingerprinting and molecular imaging. For two months a year the spectroscopy system will be coupled to the IR beamline at ....nano infrared and sub micron Raman spectroscopy and imaging. Nano infrared and sub micron raman spectroscopy and imaging: Near-field Infrared (IR) spectroscopy and imaging systems will be coupled to near-field scanning optical microscopes to provide IR spectroscopy and molecular images at less than 20 nanometre lateral resolution. This is unprecedented resolution for infrared fingerprinting and molecular imaging. For two months a year the spectroscopy system will be coupled to the IR beamline at the Australian synchrotron, to provide full IR spectral coverage available to all Australian and New Zealand scientists. A confocal raman spectrometer will be upgraded to the ultraviolet to provide spectra at less than 150 nanometre resolution. These systems will provide a unique Australian resource for nanoscientists, biomedical researchers and materials scientists requiring molecular information on the nanoscale.Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE220100846
Funder
Australian Research Council
Funding Amount
$418,388.00
Summary
Ordering photon energy carriers for efficient upconversion. This project aims to tackle the major challenge of upconversion nanosystems – their brightness. It will centre on building a donor/acceptor-ordered nanosystem to improve the energy transfer efficiency in hybrid nanomaterials. This ordered system will significantly improve the brightness of hybrid nanoparticles at low irradiance. Expected outcomes include a fundamental understanding of energy transfer mechanisms at sub-nm scales and a ne ....Ordering photon energy carriers for efficient upconversion. This project aims to tackle the major challenge of upconversion nanosystems – their brightness. It will centre on building a donor/acceptor-ordered nanosystem to improve the energy transfer efficiency in hybrid nanomaterials. This ordered system will significantly improve the brightness of hybrid nanoparticles at low irradiance. Expected outcomes include a fundamental understanding of energy transfer mechanisms at sub-nm scales and a new strategy to brighten the upconversion nanomaterials. This project should push upconversion nanoscience to a new generation and provide significant benefits in ultra-sensitive biomolecular assays and in vivo bioimaging.Read moreRead less
A structure-based design approach to maximising targeting interactions. This project aims to build on a highly successful collaboration between the Australian biotechnology company Starpharma and Monash University, to better understand the design of next generation nanomaterials that home to specific target cells. The project seeks to capitalize on recent advances in dendrimer chemistry and protein engineering to explore the design of nanomaterials linked to engineered antibody fragments. The an ....A structure-based design approach to maximising targeting interactions. This project aims to build on a highly successful collaboration between the Australian biotechnology company Starpharma and Monash University, to better understand the design of next generation nanomaterials that home to specific target cells. The project seeks to capitalize on recent advances in dendrimer chemistry and protein engineering to explore the design of nanomaterials linked to engineered antibody fragments. The anticipated goal is attainment of exquisite, cell specific targeting affinity. Targeted nanomaterials have the potential to transform the clarity of imaging technologies; to facilitate the design of sensors and diagnostics that detect biochemical change in highly select cell populations and to revolutionise drug delivery.Read moreRead less
Industrial Transformation Training Centres - Grant ID: IC180100021
Funder
Australian Research Council
Funding Amount
$4,163,359.00
Summary
ARC Training Centre for the Development of Tools for Fragment Based Design. The ARC Training Centre for the Development of Tools for Fragment Based Design aims to inspire the next generation of drug discovery research leaders. It plans to provide direct experience with industry partners, training and master classes in early stage drug-discovery from industry experts. The Centre is expected to accelerate research translation and industry engagement by providing an efficient strategy for the scree ....ARC Training Centre for the Development of Tools for Fragment Based Design. The ARC Training Centre for the Development of Tools for Fragment Based Design aims to inspire the next generation of drug discovery research leaders. It plans to provide direct experience with industry partners, training and master classes in early stage drug-discovery from industry experts. The Centre is expected to accelerate research translation and industry engagement by providing an efficient strategy for the screening of a biological target and early medicinal chemistry for optimisation. The expected outcome of the Centre is to equip the trainees with the skills to make key contributions to the sustainability and growth of the sector and to provide significant capacity to address global challenges for 21st century pharmaceutical innovation.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE120100166
Funder
Australian Research Council
Funding Amount
$240,000.00
Summary
Infrared and Raman microspectroscopic equipment for biomolecular and nanostructural analysis. This project will expand the combined microspectroscopic capabilities of Deakin and Monash Universities to enable high resolution characterisation of a diverse range of components in the fields of biotechnology and nanomaterials. The facility can be applied to pinpointing co-localised compounds within cells through to characterising metal composites, carbon nano tubes and fibres.
Synthesis of novel biologically active isoflavones. Cancer and heart disease are two of the main diseases that affect our society indiscriminately and put enormous drains on our health-care resources. Therefore, discovery and development of drugs that can treat these diseases are of utmost importance. Given the established success of Novogen Ltd in the development of drugs through to human clinical trials, novel isoflavones proposed in this study may lead to the discovery of new drug leads or t ....Synthesis of novel biologically active isoflavones. Cancer and heart disease are two of the main diseases that affect our society indiscriminately and put enormous drains on our health-care resources. Therefore, discovery and development of drugs that can treat these diseases are of utmost importance. Given the established success of Novogen Ltd in the development of drugs through to human clinical trials, novel isoflavones proposed in this study may lead to the discovery of new drug leads or therapeutic agents. The project has the potential to deliver enormous commercial benefits to Australian industry and social benefits to our ageing population through provision of new, locally produced therapeutics.Read moreRead less
Designer nano-carriers for targeted hydrophobic anticancer drug delivery with enhanced bioavailability. This project will prepare novel nano-carriers for water insoluble anticancer drug delivery with enhanced bioavailability and targeted therapy. The techniques developed in this project will advance the intellectual leadership of Australia and improve therapeutic efficacy, reduce side effects, and promote good health.
Discovery Early Career Researcher Award - Grant ID: DE120101547
Funder
Australian Research Council
Funding Amount
$375,000.00
Summary
Novel smart materials: development of positively thermo-responsive polymers for biomedical applications. The project will develop novel materials, which drastically change their structure and shape on a microscopic level in response to subtle temperature changes. In modern pharmaceuticals, this smart behaviour can be exploited to cause tailored microscopic containers to open inside the body and release medicine exactly where and when it is needed.
Unravelling the immunology of complex glycolipids by chemical synthesis. This project seeks to develop new approaches to chemically synthesise bacterial and fungal glycolipids and develop a molecular-level understanding of their effect on the immune system. Bacterial and fungal glycolipids are exotic chemical species that act as danger signals to prime and modulate our innate immune responses. These complex glycolipids possess powerful immunological activities that continue to shape our understa ....Unravelling the immunology of complex glycolipids by chemical synthesis. This project seeks to develop new approaches to chemically synthesise bacterial and fungal glycolipids and develop a molecular-level understanding of their effect on the immune system. Bacterial and fungal glycolipids are exotic chemical species that act as danger signals to prime and modulate our innate immune responses. These complex glycolipids possess powerful immunological activities that continue to shape our understanding of innate immunity, yet cannot be acquired from natural sources in the quantities and purity needed. The approaches expected to be developed in the project will be used to illuminate molecular details of immune signalling through pattern recognition receptors and presentation on specialised glycolipid antigen-presenting molecules. Outcomes may include new ways to fight disease and promote health by marshalling the resources of the immune system.Read moreRead less
Programmable Organometallics for Spatiotemporal Light Control. This Project aims to develop new materials that control and modify light. The new organometallics from this Project are anticipated to display world record light intensity-dependent absorption and other phenomena. These new programmable molecules are expected to respond to environmental stimuli with precise spatial control. Anticipated outcomes of this Project include environmental sensors and a technology platform for targeted medic ....Programmable Organometallics for Spatiotemporal Light Control. This Project aims to develop new materials that control and modify light. The new organometallics from this Project are anticipated to display world record light intensity-dependent absorption and other phenomena. These new programmable molecules are expected to respond to environmental stimuli with precise spatial control. Anticipated outcomes of this Project include environmental sensors and a technology platform for targeted medical imaging and light-responsive therapies. This Project should provide significant benefits including possible commercialisation of the new materials, enhanced research capacity, training students and a postdoctoral fellow with unique skills, and the strengthening of research linkages with strategic partners.Read moreRead less